Aurobindo-Sandoz, ex-GSK expert and more—FiercePharmaAsia by Angus Liu Friday, September 7, 2018 Aurobindo buys parts of Sandoz for $1B; an ex-GSK scientist admits to stealing trade secrets; Lilly and Chi-Med's Chinese-made drug makes history.
Cipla, Zydus Cadila and more eye $1B deal for Bharat: report by Eric Sagonowsky Tuesday, September 4, 2018 Price remains a stumbling block in a potential $1 billion deal for for Indian biopharma player Bharat Serums and Vaccines.
